mitiglinide has been researched along with 1-deoxynojirimycin in 1 studies
| Studies (mitiglinide) | Trials (mitiglinide) | Recent Studies (post-2010) (mitiglinide) | Studies (1-deoxynojirimycin) | Trials (1-deoxynojirimycin) | Recent Studies (post-2010) (1-deoxynojirimycin) |
|---|---|---|---|---|---|
| 120 | 30 | 50 | 1,548 | 141 | 558 |
| Protein | Taxonomy | mitiglinide (IC50) | 1-deoxynojirimycin (IC50) |
|---|---|---|---|
| Maltase-glucoamylase, intestinal | Homo sapiens (human) | 2.366 | |
| Lysosomal acid glucosylceramidase | Homo sapiens (human) | 1 | |
| Lysosomal alpha-glucosidase | Homo sapiens (human) | 1.015 | |
| Sucrase-isomaltase, intestinal | Homo sapiens (human) | 2 | |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 1.3 | |
| Sucrase-isomaltase, intestinal | Rattus norvegicus (Norway rat) | 0.3479 | |
| Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | 1.3 | |
| Protein-lysine 6-oxidase | Homo sapiens (human) | 1 | |
| Glycogen debranching enzyme | Homo sapiens (human) | 10 | |
| Glycogen debranching enzyme | Oryctolagus cuniculus (rabbit) | 0.19 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 1.3 | |
| Alpha-amylase | Geobacillus stearothermophilus | 1.67 | |
| Neutral alpha-glucosidase AB | Homo sapiens (human) | 1.3 | |
| Lysosomal alpha-glucosidase | Rattus norvegicus (Norway rat) | 0.3125 | |
| Putative alpha-glucosidase | Oryza sativa Japonica Group (Japanese rice) | 0.04 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anno, T; Hashiramoto, M; Hirukawa, H; Kaku, K; Kanda-Kimura, Y; Kawasaki, F; Kimura, T; Matsuki, M; Mune, T; Shimoda, M; Tatsumi, F; Tawaramoto, K | 1 |
1 trial(s) available for mitiglinide and 1-deoxynojirimycin
| Article | Year |
|---|---|
Concomitant use of miglitol and mitiglinide as initial combination therapy in type 2 diabetes mellitus.
Topics: 1-Deoxynojirimycin; Aged; Biomarkers; Blood Glucose; Diabetes Mellitus, Type 2; Drug Combinations; Fasting; Female; Glycated Hemoglobin; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Isoindoles; Male; Metformin; Middle Aged; Prognosis | 2013 |